Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Follicular Lymphoma Targeted Therapy

Carla Casulo

MD

🏢University of Rochester Medical Center🌐USA

Associate Professor of Medicine

35
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Carla Casulo is a lymphoma researcher who has made seminal contributions to risk stratification in follicular lymphoma. Her definition of POD24 (progression of disease within 24 months) as a critical prognostic biomarker has transformed clinical practice. She leads Alliance group trials evaluating risk-adapted treatment strategies for follicular lymphoma.

Share:

🧪Research Fields 研究领域

FL risk stratification
Early progression FL
POD24 outcomes
FL prognostic models
Alliance clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Carla Casulo 的研究动态

Follow Carla Casulo's research updates

留下邮箱,当我们发布与 Carla Casulo(University of Rochester Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment